Incompatibility of antimalarial drugs: challenges in formulating combination products for malaria

References

• Aditya NP, Patankar S, Madhusudhan B, et al. (2010). Artemether-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity. Eur J Pharm Sci 40:1–10. doi: 10.1016/j.ejps.2010.05.007.
   PubMed Web of Science ®Google Scholar
• Bassat Q, Ogutu B, Djimde A, et al. (2015). Tailoring a pediatric formulation of artemether–lumefantrine for treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother 59:4366–74. doi: 10.1128/AAC.00014-15.
   PubMed Web of Science ®Google Scholar
• Benredouane S, Berrama T, Doufene N. (2016). Strategy of screening and optimization of process parameters using experimental design: application to amoxicillin elimination by adsorption on activated carbon. Chemometr Intell Lab Syst 155:128–37. doi: 10.1016/j.chemolab.2016.04.010.
   Web of Science ®Google Scholar
• Deen JL, von Seidlein L, Dondorp A. (2008). Therapy of uncomplicated malaria in children: a review of treatment principles, essential drugs and current recommendations. Trop Med Int Health 13:1111–30. doi: 10.1111/j.1365-3156.2008.02117.x.
   PubMed Web of Science ®Google Scholar
• Feigon J, Denny WA, Leupin W, Kearns DR. (1984). Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kinetics. J Med Chem 27:450–65. doi: 10.1021/jm00370a007.
   PubMed Web of Science ®Google Scholar
• Kinsella R, Maher T, Clegg ME. (2017). Coconut oil has less satiating properties than medium chain triglyceride oil. Physiol Behav 179:422–6. doi: 10.1016/j.physbeh.2017.07.007.
   PubMed Web of Science ®Google Scholar
• Le Bars G, Dion S, Gauthier B, et al. (2015). Oral toxicity of Miglyol 812® in the Göttingen® minipig. Regul Toxicol Pharmacol 73:930–7. doi: 10.1016/j.yrtph.2015.09.022.
   PubMed Web of Science ®Google Scholar
• Lin W, Heimbach T, Jain JP, et al. (2016). A physiologically based pharmacokinetic model to describe artemether pharmacokinetics in adult and pediatric patients. J Pharm Sci 105:3205–13. doi: 10.1016/j.xphs.2016.06.026.
   PubMed Web of Science ®Google Scholar
• Ma Y, Lu T, Zhao W, et al. (2014). Enhanced antimalarial activity by a novel artemether–lumefantrine lipid emulsion for parenteral administration. Antimicrob Agents Chemother 58:5658–65. doi: 10.1128/AAC.01428-13.
   PubMed Web of Science ®Google Scholar
• Mendes AI, Silva AC, Catita JA, et al. (2013). Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf B Biointerfaces 111:755–63. doi: 10.1016/j.colsurfb.2013.05.041.
   PubMed Web of Science ®Google Scholar
• Mhango EKG, Kalhapure RS, Jadhav M, et al. (2017). Preparation and optimization of meropenem-loaded solid lipid nanoparticles: in vitro evaluation and molecular modeling. AAPS PharmSciTech 18:2011–25. doi: 10.1208/s12249-016-0675-z.
   PubMed Web of Science ®Google Scholar
• Murack M, Messier C. (2019). The impact of lactic acid and medium chain triglyceride on blood glucose, lactate and diurnal motor activity: a re-examination of a treatment of major depression using lactic acid. Physiol Behav 208:112569. doi: 10.1016/j.physbeh.2019.112569.
   PubMed Web of Science ®Google Scholar
• Murambiwa P, Masola B, Govender T, et al. (2011). Anti-malarial drug formulations and novel delivery systems: a review. Acta Trop 118:71–9. doi: 10.1016/j.actatropica.2011.03.005.
   PubMed Web of Science ®Google Scholar
• Nnamani PO, Hansen S, Windbergs M, Lehr CM. (2014). Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm 477:208–17. doi: 10.1016/j.ijpharm.2014.10.004.
   PubMed Web of Science ®Google Scholar
• Omwoyo WN, Melariri P, Gathirwa JW, et al. (2016). Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles. Nanomedicine 12:801–9. doi: 10.1016/j.nano.2015.11.017.
   PubMed Web of Science ®Google Scholar
• Pansuriya PB, Maguire GEM, Friedrich HB. (2019). Structural characterization and thermal properties of the anti-malarial drug: lumefantrine. S Afr J Chem 72:253–62. doi: 10.17159/0379-4350/2019/v72a33.
   Web of Science ®Google Scholar
• Patel K, Sarma V, Vavia P. (2013). Design and evaluation of lumefantrine – oleic acid self nanoemulsifying ionic complex for enhanced dissolution. Daru 21:27. doi: 10.1186/2008-2231-21-27.
   PubMed Web of Science ®Google Scholar
• Prabhu P, Suryavanshi S, Pathak S, et al. (2016). Artemether–lumefantrine nanostructured lipid carriers for oral malaria therapy: enhanced efficacy at reduced dose and dosing frequency. Int J Pharm 511:473–87. doi: 10.1016/j.ijpharm.2016.07.021.
   PubMedGoogle Scholar
• Rial SA, Jutras-Carignan A, Bergeron KF, Mounier C. (2020). A high-fat diet enriched in medium chain triglycerides triggers hepatic thermogenesis and improves metabolic health in lean and obese mice. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158582. doi: 10.1016/j.bbalip.2019.158582.
   PubMed Web of Science ®Google Scholar
• Salawi A. (2022). Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv 29:1811–23. doi: 10.1080/10717544.2022.2083724.
   PubMed Web of Science ®Google Scholar
• Savla R, Browne J, Plassat V, et al. (2017). Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm 43:1743–58. doi: 10.1080/03639045.2017.1342654.
   PubMed Web of Science ®Google Scholar
• Sharma NPV, Mann S, Khar RK. (2016). Evaluation of combination drugs before the development of self-emulsifying drug delivery system. SPER J Pharm Res 1:18–23.
   Google Scholar
• Shete H, Patravale V. (2013). Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm 454:573–83. doi: 10.1016/j.ijpharm.2013.03.034.
   PubMed Web of Science ®Google Scholar
• Thorsteinsdóttir UA, Thorsteinsdóttir M. (2021). Design of experiments for development and optimization of a liquid chromatography coupled to tandem mass spectrometry bioanalytical assay. J Mass Spectrom 56:e4727. doi: 10.1002/jms.4727.
   PubMed Web of Science ®Google Scholar
• Tomar D, Lodagekar A, Gunnam A, et al. (2022). The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine. CrystEngComm 24:156–68. doi: 10.1039/D0CE01709D.
   Web of Science ®Google Scholar